Cyclooxygenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor

Molecular Vision

Volumn 17, Issue , 2011, Pages 3468-3480

  Park, Choul Yong ^a   Choi, Jong Sun ^b   Lee, Sung Jun ^a   Hwang, Sang Won ^a   Kim, Eo Jin ^a   Chuck, Roy S ^b  

^a Dongguk University   (South Korea)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CYCLOOXYGENASE 2; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MICROVASCULATURE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PTERYGIUM; STROMA CELL; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; CONJUNCTIVA; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; PTERYGIUM; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862937455     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR. The science of pterygia. Br J Ophthalmol 2010; 94:815-20. [PMID: 19515643]
2. Di Girolamo N, Chui J, Coroneo MT, Wakefield D. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res 2004; 23:195-228. [PMID: 15094131]
3. Nolan TM, DiGirolamo N, Sachdev NH, Hampartzoumian T, Coroneo MT, Wakefield D. The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium. Am J Pathol 2003; 162:567-74. [PMID: 12547714]
4. Chui J, Di Girolamo N, Wakefield D, Coroneo MT. The pathogenesis of pterygium: current concepts and their therapeutic implications. Ocul Surf 2008; 6:24-43. [PMID: 18264653]
5. Nakagami T, Murakami A, Okisaka S, Ebihara N. Mast cells in pterygium: number and phenotype. Jpn J Ophthalmol 1999; 43:75-9. [PMID: 10340786]
6. Perra MT, Maxia C, Zucca I, Piras F, Sirigu P. Immunohistochemical study of human pterygium. Histol Histopathol 2002; 17:139-49. [PMID: 11813864]
7. Golu T, Mogoantǎ L, Streba CT, Pirici DN, Mǎlǎescu D, Mateescu GO, Muţiu G. Pterygium: histological and immunohistochemical aspects. Rom J Morphol Embryol 2011; 52:153-8. [PMID: 21424047]
8. Pinkerton OD, Hokama Y, Shigemura LA. Immunologic basis for the pathogenesis of pterygium. Am J Ophthalmol 1984; 98:225-8. [PMID: 6383051]
9. Tsai YY, Chang CC, Chiang CC, Yeh KT, Chen PL, Chang CH, Chou MC, Lee H, Cheng YW. HPV infection and p53 inactivation in pterygium. Mol Vis 2009; 15:1092-7. [PMID: 19503739]
10. Chui J, Coroneo MT, Tat LT, Crouch R, Wakefield D, Di Girolamo N. Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol 2011; 178:817-27. [PMID: 21281814]
11. Hirst LW, Axelsen RA, Schwab I. Pterygium and associated ocular surface squamous neoplasia. Arch Ophthalmol 2009; 127:31-2. [PMID: 19139334]
12. Lee JK, Song YS, Ha HS, Park JH, Kim MK, Park AJ, Kim JC. Endothelial progenitor cells in pterygium pathogenesis. Eye (Lond) 2007; 21:1186-93. [PMID: 16732212]
13. Ye J, Song YS, Kang SH, Yao K, Kim JC. Involvement of bone marrow-derived stem and progenitor cells in the pathogenesis of pterygium. Eye (Lond) 2004; 18:839-43. [PMID: 15002023]
14. Chui J, Di Girolamo N, Coroneo MT, Wakefield D. The role of substance P in the pathogenesis of pterygia. Invest Ophthalmol Vis Sci 2007; 48:4482-9. [PMID: 17898269]
15. Todani A, Melki SA. Pterygium: current concepts in pathogenesis and treatment. Int Ophthalmol Clin 2009; 49:21-30. [PMID: 19125061]
16. Yanni SE, McCollum GW, Penn JS. Genetic deletion of COX-2 diminishes VEGF production in mouse retinal Muller cells. Exp Eye Res 2010; 91:34-41. [PMID: 20398651]
17. Toomey DP, Murphy JF, Conlon KC. COX-2, VEGF and tumour angiogenesis. Surgeon 2009; 7:174-80. [PMID: 19580182]
18. Oliveira TM, Sakai VT, Machado MA, Dionísio TJ, Cestari TM, Taga R, Amaral SL, Santos CF. COX-2 inhibition decreases VEGF expression and alveolar bone loss during the progression of experimental periodontitis in rats. J Periodontol 2008; 79:1062-9. [PMID: 18533784]
19. Zhu YM, Azahri NS, Yu DC, Woll PJ. Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells. BMC Cancer 2008; 8:218. [PMID: 18671849]
20. Luo H, Chen Z, Jin H, Zhuang M, Wang T, Su C, Lei Y, Zou J, Zhong B. Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer. J Exp Clin Cancer Res 2011; 30:6. [PMID: 21219643]
21. Adiguzel U, Karabacak T, Sari A, Oz O, Cinel L. Cyclooxygenase-2 expression in primary and recurrent pterygium. Eur J Ophthalmol 2007; 17:879-84. [PMID: 18050111]
22. Chiang CC, Cheng YW, Lin CL, Lee H, Tsai FJ, Tseng SH, Tsai YY. Cyclooxygenase 2 expression in pterygium. Mol Vis 2007; 13:635-8. [PMID: 17515883]
23. Karahan N, Baspinar S, Ciris M, Baydar CL, Kapucuoglu N. Cyclooxygenase-2 expression in primary and recurrent pterygium. Indian J Ophthalmol 2008; 56:279-83. [PMID: 18579985]
24. Maxia C, Perra MT, Demurtas P, Minerba L, Murtas D, Piras F, Cabrera R, Ribatti D, Sirigu P. Relationship between the expression of cyclooxygenase-2 and survivin in primary pterygium. Mol Vis 2009; 15:458-63. [PMID: 19247455]
25. Johnston SCWP, Sheppard JD Jr. A comprehensive system for pterygium classification. ARVO Annual Meeting; 2004 April 25-29; Fort Lauderdale (FL).
26. Mauro J, Foster CS. Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment. Semin Ophthalmol 2009; 24:130-4. [PMID: 19437347]
27. Knop N, Knop E. Conjunctiva-associated lymphoid tissue in the human eye. Invest Ophthalmol Vis Sci 2000; 41:1270-9. [PMID: 10798640]
28. Steven P, Gebert A. Conjunctiva-associated lymphoid tissue-current knowledge, animal models and experimental prospects. Ophthalmic Res 2009; 42:2-8. [PMID: 19478534]
29. Tekelioglu Y, Turk A, Avunduk AM, Yulug E. Flow cytometrical analysis of adhesion molecules, T-lymphocyte subpopulations and inflammatory markers in pterygium. Ophthalmologica 2006; 220:372-8. [PMID: 17095882]
30. Kuwano T, Nakao S, Yamamoto H, Tsuneyoshi M, Yamamoto T, Kuwano M, Ono M. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J 2004; 18:300-10. [PMID: 14769824]
31. von Rahden BH, Stein HJ, Pühringer F, Koch I, Langer R, Piontek G, Siewert JR, Höfler H, Sarbia M. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma. Cancer Res 2005; 65:5038-44. [PMID: 15958546]
32. Miao R, Liu N, Wang Y, Li L, Yu X, Jiang Y, Li J. Coexpression of cyclooxygenase-2 and vascular endothelial growth factor in gastrointestinal stromal tumor: possible relations to pathological parameters and clinical behavior. Hepatogastroenterology 2008; 55:2012-5. [PMID: 19260469]
33. Zhang XH, Huang DP, Guo GL, Chen GR, Zhang HX, Wan L, Chen SY. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer 2008; 8:4. [PMID: 18190720]
34. Rizzo MT. Cyclooxygenase-2 in oncogenesis. Clin Chim Acta 2011; 412:671-87. [PMID: 21187081]
35. Marcovich AL, Morad Y, Sandbank J, Huszar M, Rosner M, Pollack A, Herbert M, Bar-Dayan Y. Angiogenesis in pterygium: morphometric and immunohistochemical study. Curr Eye Res 2002; 25:17-22. [PMID: 12518239]
36. Fallah Tafti MR, Khosravifard K, Mohammadpour M, Hashemian MN, Kiarudi MY. Efficacy of intralesional bevacizumab injection in decreasing pterygium size. Cornea 2011; 30:127-9. [PMID: 20885313]
37. Mandalos A, Tsakpinis D, Karayannopoulou G, Tsinopoulos I, Karkavelas G, Chalvatzis N, Dimitrakos S. The effect of subconjunctival ranibizumab on primary pterygium: a pilot study. Cornea 2010; 29:1373-9. [PMID: 20856107]
38. Teng CC, Patel NN, Jacobson L. Effect of subconjunctival bevacizumab on primary pterygium. Cornea 2009; 28:468-70. [PMID: 19411971]
39. Enkvetchakul O, Thanathanee O, Rangsin R, Lekhanont K, Suwan-Apichon O. A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results. Cornea 2011; 30:1213-8. [PMID: 21915047]
40. Gao Y, Zhang MC, Peng Y. Expression of cyclooxygenase-2 in pterygium and effects of selective cyclooxygenase-2 inhibitor on human pterygium fibroblasts. Zhonghua Yan Ke Za Zhi 2007; 43:881-4. [PMID: 18201523]
41. Nakano T, Wakabayashi I. Identification of cells expressing cyclooxygenase-2 in response to interleukin-1beta in rat aortae. J Pharmacol Sci 2010; 113:84-8. [PMID: 20424388]
42. Tanaka S, Tatsuguchi A, Futagami S, Gudis K, Wada K, Seo T, Mitsui K, Yonezawa M, Nagata K, Fujimori S, Tsukui T, Kishida T, Sakamoto C. Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma. Gut 2006; 55:54-61. [PMID: 16085694]
43. Nakao S, Kuwano T, Tsutsumi-Miyahara C, Ueda S, Kimura YN, Hamano S, Sonoda KH, Saijo Y, Nukiwa T, Strieter RM, Ishibashi T, Kuwano M, Ono M. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 betainduced neovascularization and tumor growth. J Clin Invest 2005; 115:2979-91. [PMID: 16239969]
44. Sheehan KM, Steele C, Sheahan K, O'Grady A, Leader MB, Murray FE, Kay EW. Association between cyclooxygenase-2-expressing macrophages, ulceration and microvessel density in colorectal cancer. Histopathology 2005; 46:287-95. [PMID: 15720414]
45. Kolaczkowska E, Goldys A, Kozakiewicz E, Lelito M, Plytycz B, van Rooijen N, Arnold B. Resident peritoneal macrophages and mast cells are important cellular sites of COX-1 and COX-2 activity during acute peritoneal inflammation. Arch Immunol Ther Exp (Warsz) 2009; 57:459-66. [PMID: 19885646]
46. Liu G, Lu P, Li L, Jin H, He X, Mukaida N, Zhang X. Critical role of SDF-1alpha-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization. Mol Vis 2011; 17:2129-38. [PMID: 21850188]
47. Abu El-Asrar AM, Al-Kharashi SA, Missotten L, Geboes K. Expression of growth factors in the conjunctiva from patients with active trachoma. Eye (Lond) 2006; 20:362-9. [PMID: 15818386]
48. Rundhaug JE, Mikulec C, Pavone A, Fischer SM. A role for cyclooxygenase-2 in ultraviolet light-induced skin carcinogenesis. Mol Carcinog 2007; 46:692-8. [PMID: 17443745]
49. Rundhaug JE, Fischer SM. Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis. Photochem Photobiol 2008; 84:322-9. [PMID: 18194346]